Sign inJoin waitlistJoin the waitlist

Adam D. Cohen

Director, Myeloma Immunotherapy · Penn Medicine

Credentials: · · · ·

History

Hospital of the University of Pennsylvania
Present

University of Pennsylvania School of Medicine
1999

Research

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a…
The Lancet · 2021 · 1,514 citations
CRISPR-engineered T cells in patients with refractory cancer
Science · 2020 · 1,187 citations
Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study
Journal of Clinical Oncology · 2016 · 869 citations

Alfred Garfall
37 papers
Edward Stadtmauer
36 papers
Dan Vogl
30 papers
AW
Adam Waxman
17 papers · 2 as a fellow
Carl June
15 papers
SS
Sandra Susanibar-Adaniya
15 papers
Jedd Wolchok
13 papers
Sundar Jagannath
13 papers
NR
Noopur Raje
12 papers
Ken Anderson
11 papers
AH
Alan Houghton
10 papers
Brendan Weiss
10 papers